ICPT Annual CAPEX
$568.00 K
+$171.00 K+43.07%
31 December 2022
Summary:
As of February 5, 2025, ICPT annual capital expenditures is $568.00 thousand, with the most recent change of +$171.00 thousand (+43.07%) on December 31, 2022. During the last 3 years, it has fallen by -$568.00 thousand (-50.00%).ICPT CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ICPT Quarterly CAPEX
$13.00 K
-$85.00 K-86.73%
30 September 2023
Summary:
As of February 5, 2025, ICPT quarterly capital expenditures is $13.00 thousand, with the most recent change of -$85.00 thousand (-86.73%) on September 30, 2023. Over the past year, it has dropped by -$321.00 thousand (-96.11%).ICPT Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ICPT TTM CAPEX
-$186.00 K
-$321.00 K-237.78%
30 September 2023
Summary:
As of February 5, 2025, ICPT TTM capital expenditures is -$186.00 thousand, with the most recent change of -$321.00 thousand (-237.78%) on September 30, 2023. Over the past year, it has dropped by -$1.05 million (-121.50%).ICPT TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ICPT CAPEX Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +43.1% | -96.1% | -121.5% |
3 y3 years | -50.0% | -99.0% | -108.9% |
5 y5 years | -94.5% | +100.0% | -116.4% |
ICPT CAPEX High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | ||||||
5 y | 5-year | ||||||
alltime | all time | -94.5% | -99.7% | -101.7% |
Intercept Pharmaceuticals CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2023 | - | $13.00 K(-86.7%) | -$186.00 K(-237.8%) |
June 2023 | - | $98.00 K(-133.0%) | $135.00 K(-76.2%) |
Dec 2022 | $568.00 K(+43.1%) | -$297.00 K(-188.9%) | $568.00 K(-34.3%) |
Sept 2022 | - | $334.00 K(-36.3%) | $865.00 K(+62.9%) |
June 2022 | - | $524.00 K(+7385.7%) | $531.00 K(+1866.7%) |
Mar 2022 | - | $7000.00(>+9900.0%) | $27.00 K(-93.2%) |
Dec 2021 | $397.00 K(-89.8%) | $0.00(0.0%) | $397.00 K(-82.7%) |
Sept 2021 | - | $0.00(-100.0%) | $2.30 M(-36.7%) |
June 2021 | - | $20.00 K(-94.7%) | $3.63 M(-5.4%) |
Mar 2021 | - | $377.00 K(-80.2%) | $3.84 M(-1.4%) |
Dec 2020 | $3.89 M(+242.5%) | $1.90 M(+42.7%) | $3.89 M(+86.6%) |
Sept 2020 | - | $1.33 M(+489.4%) | $2.08 M(+170.8%) |
June 2020 | - | $226.00 K(-47.7%) | $770.00 K(-7.8%) |
Mar 2020 | - | $432.00 K(+354.7%) | $835.00 K(-26.5%) |
Dec 2019 | $1.14 M(+580.2%) | $95.00 K(+458.8%) | $1.14 M(-2.3%) |
Sept 2019 | - | $17.00 K(-94.2%) | $1.16 M(+1.5%) |
June 2019 | - | $291.00 K(-60.3%) | $1.15 M(+41.3%) |
Mar 2019 | - | $733.00 K(+500.8%) | $811.00 K(+385.6%) |
Dec 2018 | $167.00 K(-98.4%) | $122.00 K(>+9900.0%) | $167.00 K(-50.1%) |
Sept 2018 | - | $0.00(-100.0%) | $335.00 K(-84.8%) |
June 2018 | - | -$44.00 K(-149.4%) | $2.20 M(-65.9%) |
Mar 2018 | - | $89.00 K(-69.3%) | $6.46 M(-37.9%) |
Dec 2017 | $10.39 M | $290.00 K(-84.4%) | $10.39 M(-7.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2017 | - | $1.86 M(-55.8%) | $11.18 M(+22.4%) |
June 2017 | - | $4.21 M(+4.7%) | $9.13 M(+36.3%) |
Mar 2017 | - | $4.03 M(+274.8%) | $6.70 M(+31.9%) |
Dec 2016 | $5.08 M(-14.4%) | $1.07 M(-690.1%) | $5.08 M(+12.2%) |
Sept 2016 | - | -$182.00 K(-110.2%) | $4.53 M(-23.9%) |
June 2016 | - | $1.78 M(-26.0%) | $5.95 M(-7.3%) |
Mar 2016 | - | $2.41 M(+362.0%) | $6.41 M(+8.0%) |
Dec 2015 | $5.93 M(+27.8%) | $521.00 K(-57.9%) | $5.93 M(-6.8%) |
Sept 2015 | - | $1.24 M(-44.9%) | $6.37 M(-22.3%) |
June 2015 | - | $2.25 M(+16.4%) | $8.20 M(+30.7%) |
Mar 2015 | - | $1.93 M(+102.5%) | $6.27 M(+35.1%) |
Dec 2014 | $4.64 M(+185.0%) | $953.00 K(-68.9%) | $4.64 M(-10.7%) |
Sept 2014 | - | $3.07 M(+852.2%) | $5.20 M(+135.1%) |
June 2014 | - | $322.20 K(+7.5%) | $2.21 M(+15.2%) |
Mar 2014 | - | $299.80 K(-80.1%) | $1.92 M(+17.9%) |
Dec 2013 | $1.63 M(+4098.5%) | $1.51 M(+1754.6%) | $1.63 M(+1098.7%) |
Sept 2013 | - | $81.30 K(+160.6%) | $135.90 K(+126.5%) |
June 2013 | - | $31.20 K(+258.6%) | $60.00 K(+116.6%) |
Mar 2013 | - | $8700.00(-40.8%) | $27.70 K(-28.6%) |
Dec 2012 | $38.80 K(-38.2%) | $14.70 K(+172.2%) | $38.80 K(+61.0%) |
Sept 2012 | - | $5400.00(-590.9%) | $24.10 K(+28.9%) |
June 2012 | - | -$1100.00(-105.6%) | $18.70 K(-5.6%) |
Mar 2012 | - | $19.80 K | $19.80 K |
Dec 2011 | $62.80 K | - | - |
FAQ
- What is Intercept Pharmaceuticals annual capital expenditures?
- What is the all time high annual CAPEX for Intercept Pharmaceuticals?
- What is Intercept Pharmaceuticals annual CAPEX year-on-year change?
- What is Intercept Pharmaceuticals quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Intercept Pharmaceuticals?
- What is Intercept Pharmaceuticals quarterly CAPEX year-on-year change?
- What is Intercept Pharmaceuticals TTM capital expenditures?
- What is the all time high TTM CAPEX for Intercept Pharmaceuticals?
- What is Intercept Pharmaceuticals TTM CAPEX year-on-year change?
What is Intercept Pharmaceuticals annual capital expenditures?
The current annual CAPEX of ICPT is $568.00 K
What is the all time high annual CAPEX for Intercept Pharmaceuticals?
Intercept Pharmaceuticals all-time high annual capital expenditures is $10.39 M
What is Intercept Pharmaceuticals annual CAPEX year-on-year change?
Over the past year, ICPT annual capital expenditures has changed by +$171.00 K (+43.07%)
What is Intercept Pharmaceuticals quarterly capital expenditures?
The current quarterly CAPEX of ICPT is $13.00 K
What is the all time high quarterly CAPEX for Intercept Pharmaceuticals?
Intercept Pharmaceuticals all-time high quarterly capital expenditures is $4.21 M
What is Intercept Pharmaceuticals quarterly CAPEX year-on-year change?
Over the past year, ICPT quarterly capital expenditures has changed by -$321.00 K (-96.11%)
What is Intercept Pharmaceuticals TTM capital expenditures?
The current TTM CAPEX of ICPT is -$186.00 K
What is the all time high TTM CAPEX for Intercept Pharmaceuticals?
Intercept Pharmaceuticals all-time high TTM capital expenditures is $11.18 M
What is Intercept Pharmaceuticals TTM CAPEX year-on-year change?
Over the past year, ICPT TTM capital expenditures has changed by -$1.05 M (-121.50%)